Cumberland Pharmaceuticals (CPIX) Operating Leases (2019 - 2026)

Cumberland Pharmaceuticals has disclosed Operating Leases across 8 years of filings, most recently posting $4.8 million for Q1 2026.

• Operating Leases for Q1 2026 came in at $4.8 million, down 7.14% year-over-year; the trailing twelve-month figure through Mar 2026 was $4.8 million (down 7.14% YoY), and the FY2025 annual result was $4.9 million, changed 0.0% from the prior year.
• Operating Leases came in at $4.8 million for Q1 2026 at Cumberland Pharmaceuticals, down from $4.9 million in the prior quarter.
• In the past five years, Operating Leases ranged from a high of $5.8 million in Q2 2023 to a low of $22712.0 in Q1 2022.
• The 5-year median for Operating Leases is $5.0 million (2025), against an average of $4.3 million.
• Across the five-year window, Operating Leases sank 98.76% in 2022 and jumped 20627.01% in 2023, its largest moves.
• Cumberland Pharmaceuticals' Operating Leases stood at $4.6 million in 2022, then gained by 15.48% to $5.3 million in 2023, then dropped by 6.73% to $4.9 million in 2024, then changed by 0.0% to $4.9 million in 2025, then decreased by 2.24% to $4.8 million in 2026.
• The last three Operating Leases figures came in at $4.8 million (Q1 2026), $4.9 million (Q4 2025), and $5.0 million (Q3 2025), per Business Quant data.